Project Details
Description
Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)
| Status | Active |
|---|---|
| Effective start/end date | 2/5/25 → 2/4/36 |
Funding
- SANOFI PASTEUR
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.